Avricore Health Inc. AVCR
TSXV · Canada · Health Technology
CAD 0.05500.00 (0.00%)
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
VANCOUVER, British Columbia, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that NHS England has confirmed the national expansion of the Barts Health pharmacy cholesterol testing programme powered by Avricore’s HealthTab™ platform. Approximately 100 pharmacies across England will begin offering seven-minute cholesterol checks this fall as part of a national NHS initiative aimed at identifying cardiovascular risk earlier and reducing heart attacks and
VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share. All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements
Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.7% and th
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.